Search Details

Word: abramson (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

...Richardson earned the Abramson Award for her commitment to the interests of undergraduates...

Author: By Jacqueline A. Newmyer, CRIMSON STAFF WRITER | Title: Denied Tenure, Richardson To Depart | 2/2/2000 | See Source »

Michael P. Abate Deborah A. Abeles Brian T. Abrams Michael S. Abramson Jaylaan Ahmad-Llewellyn Fahim Ahmed Stephanie N. Ajudua Rima Al-Mokarrab Michael E. Aldous Georgia N. Alexakis Jen J. B. Allen James A. Allison Elise B. Alschuler Mia C. R. Alvar Maneesh R. Amancharla Christopher A. Amar Jessie M. Amberg Richard H. Amberg Caitlin E. Anderson Blair M. Andresen Becky M. Antar Azunna E. Anyanwu Christina E. Anzuoni Patrick R. Aquino Ethan D. S. Ard Adam I. Arenson Eric R. Ashley David C. Atherton William F. Austin Erin L. Autry Irina Babushkina Daniel B. Baer Anna M. Baldwin...

Author: NO WRITER ATTRIBUTED | Title: Fifteen Minutes: World Famous | 12/16/1999 | See Source »

...Clearly, then, Two Stories owes much of its musical success to Bennett's complete dedication to music. "That album was all eight classes for Al last year," says Bennett's roommate, Mike Abramson '00. "It took up so much of his time...

Author: By Myung Joh, Jennifer Liao, and Dan L. Wagner, CONTRIBUTING WRITERSS | Title: Finding Release | 11/19/1999 | See Source »

Those statistics could spell trouble. Dr. Jon Abramson, chairman of the pediatrics academy's immunization committee, recalls that between 1989 and 1991, when many people were becoming wary of vaccines, measles-immunization rates dropped 10% and an outbreak ensued, resulting in 55,000 cases, several thousand hospitalizations and 120 deaths. "Since we started immunizing again," Abramson says, "there have been very few outbreaks of indigenous measles...

Author: /time Magazine | Title: Vaccine Jitters | 9/13/1999 | See Source »

...Steven Abramson, chairman of the FDA advisory panel, was impressed--and not at all surprised that the big drug companies were kicking up a fuss. "The cox-2 inhibitor will make it very difficult for them to compete," he says. Which could explain why Merck, Johnson & Johnson and Glaxo Wellcome are rushing to get their own versions into trial as fast as possible...

Author: /time Magazine | Title: The Great Pain Debate | 12/14/1998 | See Source »

Previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | Next